Expertise in
6
conditions

Matthew J. Streetly

Guys And St Thomas' NHS Trust
London, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
Guys And St Thomas' NHS Trust
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Matthew Streetly practices in London, United Kingdom. Mr. Streetly is highly rated in 6 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Plasmacytoma, Castleman Disease, Lymphoid Hyperplasia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 47 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Guys and St Thomas' NHS Trust
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease
ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease
Enrollment Status: Recruiting
Publish Date: August 08, 2025
Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Untreated Transplant-eligible Patients with Symptomatic MM to Evaluate the Benefit of Upfront ASCT
Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Untreated Transplant-eligible Patients with Symptomatic MM to Evaluate the Benefit of Upfront ASCT
Enrollment Status: Active_not_recruiting
Publish Date: December 06, 2024
Intervention Type: Procedure, Drug
Study Drug: Consolidation with 4 cycles of CarCyDex
Study Phase: Phase 2
A Single Arm Open Labeled Multicentre Phase 1b Dose Escalation Study of Carfilzomib Taken in Combination With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
A Single Arm Open Labeled Multicentre Phase 1b Dose Escalation Study of Carfilzomib Taken in Combination With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
Enrollment Status: Completed
Publish Date: April 15, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS
Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS
Enrollment Status: Unknown
Publish Date: September 02, 2020
Intervention Type: Other
View 3 Less Clinical Trials

47 Total Publications

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.
Journal: Blood advances
Published: July 30, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Streetly's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile